A case of Parturiunt montes, nascetur ridiculus mus? the BMA Nutrition Committee 1947-1950 and the political disengagement of nutrition science.

J Hist Med Allied Sci

University of Aberdeen, College of Arts and Social Science, School of Divinity, History and Philosophy, Old Aberdeen.

Published: April 2004

During spring 1947, there was a controversy about the consequences for health of food rationing in Britain; among the issues at stake being the accusation that government departments were failing to release relevant data. The British Medical Association (BMA) responded by establishing a Nutrition Committee to investigate the effects of rationing. Leading members of the BMA expected the committee to intervene decisively in the debate, presenting the medical profession as protectors of the people. The committee, however, was dominated by officials and others who were concerned with presenting the government's record in a good light. Furthermore, by the time the committee reported, the food situation had improved. In the event, the BMA's Nutrition Report was deemed a success if it was received quietly by the press. The deliberations of the committee had involved the controlled release of government data to interested parties, and took place during a period of transition in the government's work in nutrition, from comprehensive emergency intervention toward routine peacetime surveillance. By providing a new set of standards that were used for measuring the adequacy of diets as revealed by the annual National Food Survey, the report contributed to the establishment of the postwar modus operandi of nutrition science and the peacetime system for monitoring the health of the nation.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jhmas/jrh068DOI Listing

Publication Analysis

Top Keywords

nutrition committee
8
nutrition science
8
nutrition
6
committee
6
case parturiunt
4
parturiunt montes
4
montes nascetur
4
nascetur ridiculus
4
ridiculus mus?
4
mus? bma
4

Similar Publications

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells.

Cytotherapy

January 2025

Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Division of Hematology, University of Toronto, Toronto, Ontario, Canada. Electronic address:

The December 2024 US Food and Drug Administration (FDA) approval of Mesoblast's Ryoncil (remestemcel-L-rknd)-allogeneic bone marrow mesenchymal stromal cell (MSC(M)) therapy-in pediatric acute steroid-refractory graft-versus-host-disease finally ended a long-lasting drought on approved MSC clinical products in the United States. While other jurisdictions-including Europe, Japan, India, and South Korea-have marketed autologous or allogeneic MSC products, the United States has lagged in its approval. The sponsor's significant efforts and investments, working closely with the FDA addressing concerns regarding clinical efficacy and consistent MSC potency through an iterative process that spanned several years, was rewarded with this landmark approval.

View Article and Find Full Text PDF

Background: Iron deficiency (ID) is the most common nutritional deficiency among patients undergoing major surgery. Treatment of ID is straightforward, however implementing a comprehensive anemia management strategy within clinical routines is complex. Recently, reticulocyte hemoglobin content (Ret-He) has been evaluated as an early marker for ID diagnosis.

View Article and Find Full Text PDF

Background: Developing interventions along with the population of interest using systems thinking is a promising method to address the underlying system dynamics of overweight. The purpose of this study is twofold: to gain insight into the perspectives of adolescents regarding: (1) the system dynamics of energy balance-related behaviours (EBRBs) (physical activity, screen use, sleep behaviour and dietary behaviour); and (2) underlying mechanisms and overarching drivers of unhealthy EBRBs.

Methods: We conducted Participatory Action Research (PAR) to map the system dynamics of EBRBs together with adolescents aged 10-14 years old living in a lower socioeconomic, ethnically diverse neighbourhood in Amsterdam East, the Netherlands.

View Article and Find Full Text PDF

Metabolic profiles of meconium in preeclamptic and normotensive pregnancies.

Metabolomics

January 2025

Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Introduction: Preeclampsia (PE) is a common vascular pregnancy disorder affecting maternal and fetal metabolism with severe immediate and long-term consequences in mothers and infants. During pregnancy, metabolites in the maternal circulation pass through the placenta to the fetus. Meconium, a first stool of the neonate, offers a view to maternal and fetoplacental unit metabolism and could add to knowledge on the effects of PE on the fetus and newborn.

View Article and Find Full Text PDF

Hereditary colorectal cancer syndromes and inflammatory bowel disease: results from a registry-based study.

Int J Colorectal Dis

January 2025

Hereditary Digestive Tract Tumors Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, 20133, Milan, Italy.

Purpose: In this study, we investigated the progression of high-grade dysplasia (HGD)/CRC in patients with hereditary colorectal cancer syndromes (HCSS) and concomitant inflammatory bowel diseases (IBDs).

Methods: We described the natural history of a series of patients with confirmed diagnosis of hereditary colorectal cancer syndromes (HCCSs) and concomitant IBDs who were referred to the Hereditary Digestive Tumors Registry at the Fondazione IRCCS Istituto Nazionale dei Tumori of Milan.

Results: Between January 1989 and April 2024, among 450 patients with APC-associated polyposis and 1050 patients with Lynch syndrome (LS), we identified six patients with IBDs (five with UC, one with ileal penetrating CD) and concomitant HCCSs (five with LS, one with APC-associated polyposis).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!